These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 28987540)
1. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway. Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540 [TBL] [Abstract][Full Text] [Related]
2. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats. Lian R; Chen Y; Xu Z; Zhang X Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497 [TBL] [Abstract][Full Text] [Related]
3. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899 [TBL] [Abstract][Full Text] [Related]
5. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts. Cáceres FT; Gaspari TA; Samuel CS; Pinar AA FASEB J; 2019 Dec; 33(12):14717-14733. PubMed ID: 31689135 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats. Sun L; Jin H; Sun L; Chen S; Huang Y; Liu J; Li Z; Zhao M; Sun Y; Tang C; Zhao B; Du J Mol Med; 2015 Jan; 20(1):503-15. PubMed ID: 25222913 [TBL] [Abstract][Full Text] [Related]
7. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling. Sassoli C; Chellini F; Pini A; Tani A; Nistri S; Nosi D; Zecchi-Orlandini S; Bani D; Formigli L PLoS One; 2013; 8(5):e63896. PubMed ID: 23704950 [TBL] [Abstract][Full Text] [Related]
8. BNIP3L promotes cardiac fibrosis in cardiac fibroblasts through [Ca Liu W; Wang X; Mei Z; Gong J; Huang L; Gao X; Zhao Y; Ma J; Qian L Sci Rep; 2017 May; 7(1):1906. PubMed ID: 28507335 [TBL] [Abstract][Full Text] [Related]
9. ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-β1/Smad Signaling Pathway. Yuan Q; Cao S; Dong Q; Wang Z; Xu Y; Han Q; Ma J; Wei S; Pang J; Yang F; Zhang R; Liu B; Dai S; Xue L; Wang J; Xue M; Xu T; Zheng W; Xu F; Chen Y; Guo P J Cardiovasc Pharmacol; 2019 Apr; 73(4):248-256. PubMed ID: 30801261 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway. Li B; Chen H; Yang X; Wang Y; Qin L; Chu Y Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):97-101. PubMed ID: 27453280 [TBL] [Abstract][Full Text] [Related]
11. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway. Jin D; Han F J Recept Signal Transduct Res; 2020 Dec; 40(6):493-500. PubMed ID: 32496870 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGFβRI on cardiac fibroblasts. Zhao X; Wang K; Liao Y; Zeng Q; Li Y; Hu F; Liu Y; Meng K; Qian C; Zhang Q; Guan H; Feng K; Zhou Y; Du Y; Chen Z Cell Physiol Biochem; 2015; 35(1):213-26. PubMed ID: 25591764 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation. Rizvi F; Siddiqui R; DeFranco A; Homar P; Emelyanova L; Holmuhamedov E; Ross G; Tajik AJ; Jahangir A Int J Cardiol; 2018 Nov; 270():228-236. PubMed ID: 30220377 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling. Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583 [TBL] [Abstract][Full Text] [Related]
15. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition. Zhao L; Mi Y; Guan H; Xu Y; Mei Y Eur J Pharmacol; 2016 Jul; 783():33-46. PubMed ID: 27108788 [TBL] [Abstract][Full Text] [Related]
16. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation. Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247 [TBL] [Abstract][Full Text] [Related]
17. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701 [TBL] [Abstract][Full Text] [Related]
18. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1. Ma J; Ma SY; Ding CH Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464 [TBL] [Abstract][Full Text] [Related]
19. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction. Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222 [TBL] [Abstract][Full Text] [Related]
20. Osthole inhibits the expressions of collagen I and III through Smad signaling pathway after treatment with TGF-β1 in mouse cardiac fibroblasts. Liu JC; Wang F; Xie ML; Cheng ZQ; Qin Q; Chen L; Chen R Int J Cardiol; 2017 Feb; 228():388-393. PubMed ID: 27870967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]